Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
scp776 for brain injury after out-of-hospital cardiac arrest
ACTRN12623001276640Phase 2Not yet recruiting
- Sponsor
- Austin Hospital
- Start
- Feb 2025
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in cardiac arrest (SCA) and hypoxic-ischemic encephalopathy (HIE) comparing scp776 with placebo (2 arms). Primary endpoint: Volume of brain injury on MRI. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
scp776
03
Conditions
cardiac arrest (SCA)hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on ACTRN12623001276640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623001276640.